IE 11 is a very old Browser and it`s not supported on this site
Business report Performance

Performance / Multi-year comparison

Indexed performance since launch (in CHF)

BB Biotech AG (SIX)-CHF

Platzhaltergrafik


Annual performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

2020

 

19.3%

 

24.3%

 

15.8%

2019

 

18.5%

 

23.4%

 

23.0%

2018

 

(5.2%)

 

(14.5%)

 

(8.0%)

2017

 

22.9%

 

23.4%

 

16.4%

2016

 

0.2%

 

(19.3%)

 

(19.8%)

Cumulated performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

19.3%

 

24.3%

 

15.8%

1 year

 

19.3%

 

24.3%

 

15.8%

3 years

 

34.1%

 

31.1%

 

31.1%

5 years

 

65.1%

 

30.6%

 

22.1%

since inception 1)

 

2 849%

 

2 585%

 

1 353%

1 11/09/1993

Annualized performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

19.3%

 

24.3%

 

15.8%

3 years

 

10.3%

 

9.5%

 

9.4%

5 years

 

10.6%

 

5.5%

 

22.1%

since inception 1)

 

13.3%

 

12.9%

 

10.4%

1 11/09/1993

BB BIOTECH AG (XETRA)-EUR

Platzhaltergrafik


Annual performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

2020

 

18.1%

 

24.8%

 

16.1%

2019

 

23.4%

 

28.1%

 

27.6%

2018

 

(2.2%)

 

(11.1%)

 

(4.3%)

2017

 

12.9%

 

12.5%

 

6.7%

2016

 

1.7%

 

(17.8%)

 

(19.0%)

Cumulated performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

18.1%

 

24.8%

 

16.1%

1 year

 

18.1%

 

24.8%

 

16.1%

3 years

 

42.5%

 

42.0%

 

41.8%

5 years

 

63.7%

 

31.4%

 

22.6%

since inception 1)

 

2 243%

 

2 057%

 

1 365%

1 12/10/1997

Annualized performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

18.1%

 

24.8%

 

16.1%

3 years

 

12.5%

 

12.4%

 

12.3%

5 years

 

10.4%

 

5.6%

 

4.2%

since inception 1)

 

14.6%

 

14.2%

 

12.4%

1 12/10/1997

BB BIOTECH AG (MILAN)-EUR

Platzhaltergrafik


Annual performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

2020

 

19.7%

 

24.8%

 

16.1%

2019

 

22.6%

 

28.1%

 

27.6%

2018

 

(1.3%)

 

(11.1%)

 

(4.3%)

2017

 

12.2%

 

12.5%

 

6.7%

2016

 

1.2%

 

(17.8%)

 

(19.0%)

Cumulated performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

YTD

 

19.7%

 

24.8%

 

16.1%

1 year

 

19.7%

 

24.8%

 

16.1%

3 years

 

44.8%

 

42.0%

 

41.8%

5 years

 

64.4%

 

31.4%

 

22.6%

since inception 1)

 

445%

 

398%

 

177%

1 10/19/2000

Annualized performance

12/31/2020

 

 

SHARE

 

NAV

 

NBI TR

1 year

 

19.7%

 

24.8%

 

16.1%

3 years

 

13.1%

 

12.4%

 

12.3%

5 years

 

10.5%

 

5.6%

 

4.2%

since inception 1)

 

8.8%

 

8.3%

 

5.2%

1 10/19/2000

Multi-year comparison

 

 

2020

 

2019

 

2018

 

2017

 

2016

 

 

Market capitalization at the end of the period (in CHF mn)

 

4 107.9

 

3 670.3

 

3 235.4

 

3 576.1

 

3 052.5

 

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

 

3 887.5

 

3 393.0

 

2 884.5

 

3 538.7

 

3 003.0

 

highchart-toggle

Number of shares (in mn) 1)

 

55.4

 

55.4

 

55.4

 

55.4

 

55.4

 

highchart-toggle

Trading volume (in CHF mn)

 

2 315.6

 

2 004.2

 

2 610.7

 

2 864.7

 

3 204.5

 

highchart-toggle

Profit/(loss) (in CHF mn)

 

691.2

 

677.4

 

(471.3)

 

687.5

 

(802.1)

 

highchart-toggle

Closing price at the end of the period in CHF 1)

 

74.15

 

66.25

 

58.40

 

64.55

 

55.10

 

highchart-toggle

Closing price (G) at the end of the period in EUR 1)

 

68.00

 

61.40

 

52.00

 

55.68

 

51.70

 

highchart-toggle

Closing price (I) at the end of the period in EUR 1)

 

68.50

 

61.00

 

52.00

 

55.20

 

51.60

 

highchart-toggle

Stock performance (incl. distributions) 2)

 

19.3%

 

18.5%

 

(5.2%)

 

22.9%

 

0.2%

 

highchart-toggle

High/low share price in CHF 1)

 

74.70/45.44

 

73.20/59.35

 

74.10/56.10

 

67.80/52.10

 

58.20/40.78

 

highchart-toggle

High/low share price in EUR 1)

 

69.00/43.04

 

64.70/52.10

 

64.80/48.60

 

59.10/48.42

 

53.98/36.74

 

highchart-toggle

Premium/(discount) (annual average)

 

9.2%

 

11.8%

 

9.7%

 

(2.5%)

 

(5.1%)

 

highchart-toggle

Cash distribution / dividend in CHF (*proposal) 1)

 

3.60*

 

3.40

 

3.05

 

3.30

 

2.75

 

highchart-toggle

Degree of investment (quarterly figures)

 

106.8%

 

109.1%

 

108.4%

 

103.1%

 

109.9%

 

highchart-toggle

Total Expense Ratio (TER) p.a. 3)

 

1.25%

 

1.26%

 

1.25%

 

1.27%

 

1.30%

 

highchart-toggle

1 Five-for-one share split as at March 29, 2016 considered

2 All figures in CHF %, total return-methodology

3 Based on market capitalization

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience.Use of cookies & disclaimer